News | January 09, 2025
GEON Performance Solutions acquires Foster Corporation
Acquisition expands high-value medical platform
Acquisition expands high-value medical platform
The facility is equipped with state-of-the-art technology to produce high-quality lyophilized (freeze-dried) products
Partnership to supercharge LVMH Recherche with Integrated Biosciences’ innovative AI and synthetic biology platform for targeting skin aging
The company plans to advance Ropanicant into double-blind, placebo-controlled Phase-2b clinical study in MDD patients, anticipated to start in early 2025
Grant funding from the Bill & Melinda Gates Foundation will support the rapid and efficient design and synthesis of novel small molecules
Studies suggest that the protein Sclerostin plays a key role in the dysregulation of bone metabolism
Boehringer Ingelheim aims to develop this program as a potential key centerpiece component for its immuno-oncology portfolio
Sapala has a strong customer base including innovator Pharma, CDMOs & diagnostic companies
Merck shared updates on the company’s oncology pipeline and focused R&D approach
225Ac-PSMA-Trillium is an investigational next-generation PSMA-targeted alpha therapy with potential to treat patients with advanced metastatic prostate cancer
Subscribe To Our Newsletter & Stay Updated
